ITGB1 studies in cancer have so far been restricted to a particular cancer species; Therefore, ITGB1 must be subjected to a pan-cancer analysis in order to better understand its interactions with the underlying molecular mechanisms of action and the tumor immune microenvironment. This evidence concerns the gene ITGB1 and neoplasm.